← Open Payments lookup

SAMEEN BOZAI: Open Payments

NPI 1508519240 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,045 in 50 payments from 11 companies in 2025. Trend: 2023 $4,253 · 2024 $1,314 · 2025 $1,045

Food & beverage: $1,045
CompanyPaymentsAmount
ABBVIE INC.16$325
Otsuka America Pharmaceutical, Inc.12$284
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$178
AstraZeneca Pharmaceuticals LP4$79
Novo Nordisk Inc3$64
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Optinose US, Inc.1$22
Lilly USA, LLC1$20
Daiichi Sankyo Inc.1$20
Exact Sciences Corporation1$19

Products named: REXULTI, CAPLYTA, VRAYLAR, QULIPTA, Wegovy, FARXIGA, BREZTRI, JARDIANCE.

Industry payments across VA — which companies pay providers there.